MULTAQ for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 83 adverse event reports in the FDA FAERS database where MULTAQ was used for Atrial fibrillation.
Most Reported Side Effects for MULTAQ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Atrial fibrillation | 49 | 39.5% | 0 | 8 |
| Dyspnoea | 12 | 9.7% | 0 | 3 |
| Blood creatinine increased | 9 | 7.3% | 0 | 1 |
| Fatigue | 8 | 6.5% | 0 | 2 |
| Drug ineffective | 6 | 4.8% | 0 | 2 |
| Nausea | 6 | 4.8% | 1 | 2 |
| Cough | 5 | 4.0% | 0 | 1 |
| Dizziness | 5 | 4.0% | 0 | 2 |
| Heart rate increased | 5 | 4.0% | 0 | 2 |
| Malaise | 5 | 4.0% | 0 | 2 |
| Renal impairment | 5 | 4.0% | 0 | 1 |
Other Indications for MULTAQ
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)